Skip to main content
Log in

Organ Transportation Innovations and Future Trends

  • Expanding Role of Technology in Organ Transplant (D Axelrod and J Scalea, Section Editors)
  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Transplantation evolved dramatically since the first organ transplant in 1954. Rapid increases in knowledge of immunology and surgical care outpaced the organ transportation infrastructure for organ shipment. Current allocation strategies have necessitated donor organs travelling longer distances over greater periods of time, potentially affecting rates of graft survival, delayed graft function (DGF), or primary graft nonfunction (PNF).

Recent Findings

Organ transportation and preservation are intimately related because the longer an organ can be maintained ex vivo, the wider the array of possible shipping modalities. Innovations in organ preservation and shipment allow for optimization of allocation strategies.

Summary

Innovative technologies such as on demand shipment of organs using unmanned aerial vehicles (i.e. drones), the use of smart tools for real-time organ monitoring, and normothermic and hypothermic donor organ perfusion hold great promise for equitable, safe, and durable distribution of high-quality donor organs to matched recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of major importance

  1. OPTN, SRTR 2019. Annual Data Report: Introduction. American Journal of Transplantation. 2021;21:11–20.

    Google Scholar 

  2. 1988–2021 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994–2003.

  3. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333:333–6.

    Article  CAS  Google Scholar 

  4. Patzer R, Knechtle S Kidney transplantation: principles and practice. (Elsevier, 2014).

  5. Stegall MD, Stock PG, Andreoni K, Friedewald JJ, Leichtman AB. Why do we have the kidney allocation system we have today? A history of the 2014 kidney allocation system. Hum Immunol. 2017;78:4–8.

    Article  Google Scholar 

  6. Friedewald JJ, et al. The Kidney Allocation System. Surg Clin North Am. 2013;93:1395–406.

    Article  Google Scholar 

  7. Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res. 2005;3:87–92.

    Article  Google Scholar 

  8. Massie AB, et al. Early changes in liver distribution following implementation of Share 35. Am J Transplant. 2015;15:659–67.

    Article  CAS  Google Scholar 

  9. Bowring MG, et al. Geographic disparity in deceased donor liver transplant rates following Share 35. Transplantation. 2019;103:2113–20.

    Article  Google Scholar 

  10. Zhou S, et al. Geographic disparity in kidney transplantation under <scp>KAS</scp>. Am J Transplant. 2018;18:1415–23.

    Article  Google Scholar 

  11. Current opinions in organ allocation. Am J Transplant. 2018;18:2625–34.

    Article  Google Scholar 

  12. Stewart DE, et al. Changes in deceased donor kidney transplantation one year after KAS implementation. Am J Transplant. 2016;16:1834–47.

    Article  CAS  Google Scholar 

  13. Englesbe MJ, et al. Improving organ procurement travel practices in the United States: proceedings from the Michigan Donor Travel Forum. Am J Transplant. 2010;10:458–63.

    Article  CAS  Google Scholar 

  14. • Englesbe, M. J. & Merion, R. M. The Riskiest Job in Medicine: Transplant Surgeons and Organ Procurement Travel. Am J Transplant. 2009;9:2406-2415. Although there is no single repository of procurement travel practices and trends, this 2009 survey of transplant surgeons provides a clear measure of the relative utilization of each transportation method (21% of retrievals utilized fixed wing aircraft, 16% each for personal vehicle and car with driver, 14% by ambulance, 10% other vehicle, 5% helicopter, and 18% involving “no travel” with a donor at the recipient institution).

  15. Transplant team dies in jet crash; mechanical problems suspected. New York Times (2007).

  16. Scalea JR, Restaino S, Scassero M, Bartlett ST, Wereley N. The final frontier? Exploring organ transportation by drone. Am J Transplant. 2019;19:962–4.

    Article  Google Scholar 

  17. • Scalea, J. R. et al. An Initial Investigation of Unmanned Aircraft Systems (UAS) and Real-Time Organ Status Measurement for Transporting Human Organs. IEEE. J Transl Eng Health Med. 2018;6:4000107. This study by Scalea et al introduces a device for measuring external forces on donor organs during fixed-wing and drone-based transit (temperature, barometric pressure, altitude, vibration, and GPS location). Tissue level measurements of this kind will be critical to future organ transport studies.

  18. Huang Y, et al. Effect of airplane transport of donor livers on post-liver transplantation survival. World J Gastroenterol. 2016;22:9154–61.

    Article  Google Scholar 

  19. Kollock R, Games K, Wilson AE, Sefton JM. Effects of vehicle-ride exposure on cervical pathology: a meta-analysis. Ind Health. 2015;53:2014–156.

    Article  Google Scholar 

  20. Panjabi MM, Andersson GB, Jorneus L, Hult E, Mattsson L. In vivo measurements of spinal column vibrations. J Bone Joint Surg Am. 1986;68:695–702.

    Article  CAS  Google Scholar 

  21. Zeeman ME, et al. Whole-body vibration at thoracic resonance induces sustained pain and widespread cervical neuroinflammation in the rat. Clin Orthop Relat Res. 2015;473:2936–47.

    Article  Google Scholar 

  22. Rosser JC, Vignesh V, Terwilliger BA, Parker BC. Surgical and medical applications of drones: a comprehensive review. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2018;22:e2018.00018.

    Article  Google Scholar 

  23. Hiebert B, Nouvet E, Jeyabalan V, Donelle L. The application of drones in healthcare and health-related services in North America: a scoping review. Drones. 2020;4:30.

    Article  Google Scholar 

  24. Scalea JR, et al. Successful implementation of unmanned aircraft use for delivery of a human organ for transplantation. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003630.

    Article  PubMed  Google Scholar 

  25. MissionGO & Minnesota Team Transports World’s First Human Pancreas via Unmanned Aircraft. GlobalNewsWire (2021).

  26. Axelrod DA, et al. Improving safety in organ recovery transportation: report from the ASTS/UNOS/AST/AOPO transportation safety summit. Am J Transplant. 2020;20:2001–8.

    Article  Google Scholar 

  27. Nasralla D, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557:50–6.

    Article  CAS  Google Scholar 

  28. LembachJahnsen H, Mergental H, Perera MTPR, Mirza DF. Ex-situ liver preservation with machine preservation. Current Opinion in Organ Transplantation. 2021;26:121–32.

    Article  Google Scholar 

  29. Schlegel A, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation. J Hepatol. 2019;70:50–7.

    Article  CAS  Google Scholar 

  30. Kron P, Schlegel A, Mancina L, Clavien P-A, Dutkowski P. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol. 2018;68:82–91.

    Article  CAS  Google Scholar 

  31. Hameed AM, et al. Brief normothermic machine perfusion rejuvenates discarded human kidneys. Transplantation Direct. 2019;5:e502.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph R. Scalea.

Ethics declarations

Conflict of Interest

Dr. Scalea holds patents in organ preservation and the University of Maryland. Dr. Scalea founded the company MediGO, Inc. and MissionGO, Inc. which increases access to transplants using efficiency and innovated transportation models.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Expanding Role of Technology in Organ Transplant

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gavzy, S.J., Scalea, J.R. Organ Transportation Innovations and Future Trends. Curr Transpl Rep 9, 143–147 (2022). https://doi.org/10.1007/s40472-021-00341-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40472-021-00341-2

Keywords

Navigation